GEOID study

JRCT ID: jRCTs051220096

Registered date:22/09/2022

Basic Information

• Recruitment status: Recruiting
• Health condition(s) or Problem(s) studied: stomach cancer
• Date of first enrollment: 22/09/2022
• Target sample size: 32
• Study type: Interventional
• Intervention(s): External Oblique Intercostal Block (EOIB)

Outcome(s)

• Primary Outcome: Numerical rating scale (NRS) at 12 hours after surgery

Secondary Outcome

1) Numerical rating scale (NRS) at 2 hours, 1 day, and 2 days after surgery
2) Fentanyl consumption after surgery
3) Quality of Recovery score-15(QoR-15)
4) WHODAS 2.0 (WHO disability assessme nt schedule)

Key inclusion & exclusion criteria

• Age minimum: >= 20age old
• Age maximum: < 85age old
• Gender: Both

Include criteria

1) Patients scheduled laparoscopic or robot-assisted gastrectomy at Nara Medical University Hospital
2) ASA physical status 1 or 2
3) Patients aged 20 or over but under 85
4) Patients who signed the informed consent for this study

Exclude criteria

1) Patients undergoing temporary surgery who apply on the same day
2) Chronic opioid use
3) Allergy to local anesthetics
4) Communication difficulty
5) Coagulation disorder
6) Patients who weigh under 34kg
7) Patients who have received antithrombotic therapy and conflict with a sufficient period of drug withdrawal according to the guideline published by JSA/JSRA/JSPC
8) Patients who have been judged inappropriate in the study by the investigator or sub-investigator

Related Information

• Primary Sponsor: Suzuka Takanori
• Source(s) of Monetary Support: Nara Medical University